Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Predictors of Hemoglobin Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria

    ... hemoglobin for age/sex, absence of symptoms, and lactate dehydrogenase < 1.5 times the upper limit of normal. A good partial ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.

    ... immunosuppressive therapy did not have an elevated lactate dehydrogenase , nor did they experience hemolysis or thrombosis ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.

    ... showed that PNH patients with elevated hemolysis [ lactate dehydrogenase (LDH) levels ≥1.5 times the upper limit of normal (ULN)] at ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena

    ... requirements, and serum iron parameters were analyzed. Lactate dehydrogenase levels were significantly decreased by 85% from a median of ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria

    ... of hemolysis in all participants with a reduction of lactate dehydrogenase to normal levels. All hematological parameters stabilized. No ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. A Prospective Multicenter Study of Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure.

    ... other BMF (24.4%), and the percentage of patients with lactate dehydrogenase levels (a marker for intravascular hemolysis) ≥ 1.5 × ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional

    ... The multivariate analysis, including IPSS, WPSS, age, lactate dehydrogenase , ferritin concentration, Eastern Cooperative Oncology ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.

    ... other BMF (24.4%), and the percentage of patients with lactate dehydrogenase levels (a marker for intravascular hemolysis) ≥ 1.5 × ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution

    ... with older age, higher platelet counts, lower lactate dehydrogenase levels, good-risk cytogenetics and mutations of DNMT3A, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis

    ... bleeding, hematuria, and elevated plasma lactate dehydrogenase ; he started eculizumab therapy with a good response. ...

    Research Article last updated 11/02/2016 - 2:49pm.